© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.
Building a Research Consortium of Large Health Systems: The Cancer Research Network
Affiliations of authors: Group Health Cooperative Center for Health Studies, Seattle, WA (EHW, SMG, GH); Meyers Primary Care Institute, University of Massachusetts, Worcester, MA (TSF); Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care, Boston, MA (SF); Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA (AMG); Division of Research, Kaiser Permanente Northern California, Oakland, CA (LJH); Henry Ford Health System, Detroit, MI (CCJ); Kaiser Permanente Colorado, Denver, CO (JM); HealthPartners Research Foundation, Minneapolis, MN (SJR); Center for Health Research, Kaiser Permanente Northwest, Portland, OR (MCH, VJS); National Cancer Institute, Bethesda, MD (SHT); Kaiser Permanente Georgia (DT); Center for Health Research Hawaii, Kaiser Permanente Hawaii (TMV)
Correspondence to: Edward Wagner, MD, MPH, Group Health Cooperative Center for Health Studies, 1730 Minor Ave., Ste. 1600, Seattle, WA 98101 (e-mail: wagner.e{at}ghc.org).
Critical questions about cancer prevention, care, and outcomes increasingly require research involving large patient populations and their care delivery organizations. The Cancer Research Network (CRN) includes 11 integrated health systems funded by the National Cancer Institute (NCI) to conduct collaborative cancer research. This article describes the challenges of constructing a productive consortium of large health systems, and explores the CRN's responses. The CRN was initially funded through an NCI cooperative agreement in 1999 and has since received a second 4-year grant. Leadership and policy development are provided through a steering committee, subcommittees, and an external advisory committee. The CRN includes integral and affiliated research projects supported by a Scientific and Data Resources Core. Three characteristics of the CRN intensified the general challenges of consortium research: 1) its members are large health systems with legitimate concerns about confidentiality of data about enrollees, providers, and the organization; 2) CRN research projects often generate highly sensitive data about quality of care; and therefore 3) each participating organization wants a strong voice in CRN direction. CRN experience to date confirms that a consortium of health systems with internal research capacity can address a range of important cancer research questions that would be difficult to study in other venues. The advantages and challenges of consortium research are explored, with suggestions for the development, execution, and management of multisystem population laboratories.
This article has been cited by other articles:
![]() |
J. V. Lacey Jr., G. L. Mutter, B. M. Ronnett, O. B. Ioffe, M. A. Duggan, B. B. Rush, A. G. Glass, D. A. Richesson, N. Chatterjee, B. Langholz, et al. PTEN Expression in Endometrial Biopsies as a Marker of Progression to Endometrial Carcinoma Cancer Res., July 15, 2008; 68(14): 6014 - 6020. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhatia and L. L. Robison Cancer Survivorship Research: Opportunities and Future Needs for Expanding the Research Base Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1551 - 1557. [Full Text] [PDF] |
||||
![]() |
D. J. del Junco, S. W. Vernon, S. P. Coan, J. A. Tiro, L. A. Bastian, L. S. Savas, C. A. Perz, D. R. Lairson, W. Chan, C. Warrick, et al. Promoting Regular Mammography Screening I. A Systematic Assessment of Validity in a Randomized Trial J Natl Cancer Inst, March 5, 2008; 100(5): 333 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S.M. Buist, L. Ichikawa, M. N. Prout, M. U. Yood, T. S. Field, C. Owusu, A. M. Geiger, V. P. Quinn, F. Wei, and R. A. Silliman Receipt of Appropriate Primary Breast Cancer Therapy and Adjuvant Therapy Are Not Associated With Obesity in Older Women With Access to Health Care J. Clin. Oncol., August 10, 2007; 25(23): 3428 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Glass, J. V. Lacey Jr, J. D. Carreon, and R. N. Hoover Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status J Natl Cancer Inst, August 1, 2007; 99(15): 1152 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mandelblatt To Screen or Not to Screen Older Women for Breast Cancer: A New Twist on an Old Question or Will We Ever Invest in Getting the Answers? J. Clin. Oncol., July 20, 2007; 25(21): 2991 - 2992. [Full Text] [PDF] |
||||
![]() |
J. Z. Ayanian and P. B. Jacobsen Enhancing Research on Cancer Survivors J. Clin. Oncol., November 10, 2006; 24(32): 5149 - 5153. [Abstract] [Full Text] [PDF] |
||||



